(NP (NP (NN Structure) (NN function) (NN analysis)) (PP (IN of) (NP (NP (NN vitamin) (NN D) (NNS analogs)) (PP (IN with) (NP (NN C-ring) (NNS modifications))))) (. .))
(S (NP-SBJ-52 (NP (NNS Analogs)) (PP (IN of) (NP (NP (CD 1) (NN alpha,25-dihydroxyvitamin) (NN D3)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN alpha,25--LRB-OH-RRB-) (NN 2D3)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NNS substitutions)) (PP (IN on) (NP (NN C-11)))))) (VP (VBD were) (VP (VBN synthesized) (NP (-NONE- *-52)))) (. .))
(S-COOD (S (NP-SBJ (NP (JJ Small) (JJ apolar) (NNS substitutions)) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD 11) (NN alpha-methyl)) (, ,) (NP (CD 11) (NN alpha-fluoromethyl))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (ADVP (RB markedly)) (VP (VB decrease) (NP (NP (DT the) (NN affinity)) (PP (IN for) (NP (DT the) (NN vitamin) (NN D) (NN receptor))))))) (, ,) (CC but) (S (NP-SBJ (NP (ADJP-COOD (ADJP (JJR larger) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD 11) (NN alpha-chloromethyl)) (CC or) (NP (NP (CD 11) (NN alpha-)) (CC or) (CD 11) (NN beta-phenyl))) (-RRB- -RRB-))) (CC or) (ADJP (RBR more) (JJ polar))) (NNS substitutions)) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD 11) (NN alpha-hydroxymethyl)) (, ,) (NP (CD 11) (NN alpha--LRB-2-hydroxyethyl))) (-RRB- -RCB-))) (VP (VBD decreased) (NP (DT the) (NN affinity)) (PP (TO to) (NP (NP (QP (JJR less) (IN than) (CD 5)) (NN %)) (PP (IN of) (NP (NP (DT that)) (PP (IN of) (NP (CD 1) (NN alpha,25-OH-RRB-2D3))))))))) (. .))
(S (NP-SBJ (NP (PRP$ Their) (NN affinity)) (PP (IN for) (NP (DT the) (ADJP (NN vitamin) (JJ D-binding)) (NN protein)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD increased) (ADVP (RB up) (TO to) (RB 4-fold))) (. .))
(S-COOD (S (NP-SBJ (NP (DT The) (JJ biological) (NN activity)) (PP (IN of) (NP (CD 11) (NN alpha-methyl-1) (NN alpha,25--LRB-OH-RRB-2D3)))) (ADVP (RB closely)) (VP (VBD resembled) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (JJ natural) (NN hormone))) (PP (IN on) (NP (ADJP-COOD (ADJP (JJ normal)) (CC and) (ADJP (JJ leukemic))) (NP-COOD (NP (NN cell) (NN proliferation)) (CC and) (NP (NN bone) (NN resorption)))))))) (, ,) (IN whereas) (S (NP-SBJ (NP (PRP$ its) (ADJP (FW in) (FW vivo)) (NN effect)) (PP (IN on) (NP (NP (NN calcium) (NN metabolism)) (PP (IN of) (NP (DT the) (JJ rachitic) (NN chick)))))) (VP (VBD was) (NP-PRD (NP (QP (IN about) (CD 50)) (NN %)) (PP (IN of) (NP (NP (DT that)) (PP (IN of) (NP (CD 1) (NN alpha,25--LRB-OH-RRB-2D3)))))))) (. .))
(S (NP-SBJ (DT The) (CD 11) (NN beta-methyl) (NN analog)) (VP (VBD had) (NP (DT a) (ADJP (ADVP (JJR greater) (IN than) (RB 10-fold)) (JJR lower)) (NN activity))) (. .))
(S-COOD (S (NP-SBJ (NP (DT The) (JJ differentiating) (NNS effects)) (PP (IN of) (NP (DT the) (JJ other) (NN C-11) (NNS analogs))) (PP (IN on) (NP (NP (JJ human) (JJ promyeloid) (NN leukemia) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN HL-60)) (-RRB- -RRB-))))) (VP (VBD agreed) (ADVP (RB well)) (PP (IN with) (NP (PRP$ their) (NP-COOD (NP (JJ bone-resorbing) (NN activity)) (CC and) (NP (NN receptor) (NN affinity))))))) (, ,) (CC but) (S (NP-SBJ (PRP they)) (VP (VBD demonstrated) (NP (JJR lower) (JJ calcemic) (NNS effects)) (ADVP (FW in) (FW vivo)))) (. .))
(S (NP-SBJ (NP (ADJP-COOD (ADJP (JJ Large)) (CC or) (ADJP (JJ polar))) (NNS substitutions)) (PP (IN on) (NP (NP (NN C-11)) (PP (IN of) (NP (CD 1) (NN alpha,25--LRB-OH-RRB-2D3)))))) (ADVP (RB thus)) (VP-COOD (VP (VBP impair) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (DT the) (NN vitamin) (NN D) (NN receptor))))) (CC but) (VP (VBP increase) (NP (NP (DT the) (NN affinity)) (PP (TO to) (NP (ADJP (NN vitamin) (JJ D-binding)) (NN protein)))))) (. .))
(S (NP-SBJ (NP (DT The) (NNS effects)) (PP (IN of) (NP (JJ many) (JJ C-11-substituted) (CD 1) (NN alpha,25--LRB-OH-RRB-2D3) (NNS analogs))) (PP (IN on) (NP (NN HL-60) (NN cell) (NN differentiation)))) (VP (VBD exceeded) (NP (NP (PRP$ their) (NN activity)) (PP (IN on) (NP (NN calcium) (NN metabolism))))) (. .))
